Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 27Neoplasms 20Cancer Pain 10Colonic Neoplasms 7Breakthrough Pain 7Agnosia 7Breast Neoplasms 5Rectal Neoplasms 4Prostatic Neoplasms 4Lung Neoplasms 4Head and Neck Neoplasms 4Chronic Pain 4Urinary Bladder Neoplasms 3Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Pain, Postoperative 3Lymphoma, Follicular 3Breakthrough Cancer Pain 3Waldenstrom Macroglobulinemia 2Uterine Cervical Neoplasms 2Thrombocythemia, Essential 2Sezary Syndrome 2Primary Myelofibrosis 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Polycythemia Vera 2Pleural Effusion, Malignant 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Myeloproliferative Disorders 2Mycosis Fungoides 2

Interventions

Tracheostomy 1Tomography, Emission-Computed, Single-Photon 1Sodium Bicarbonate 1Saline Solution 1Fluoridation 1Fentanyl 1Esophagectomy 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Respiratory Insufficiency × Fentanyl × Clear all
NCT00696137 2019-09-24

Long-term Extension Study of BEMAâ„¢ Fentanyl

BioDelivery Sciences International

Phase 3 Completed
5 enrolled 4 charts

Respiratory Insufficiency, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡